These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 31200683

  • 1. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
    Sopo M, Anttila M, Hämäläinen K, Kivelä A, Ylä-Herttuala S, Kosma VM, Keski-Nisula L, Sallinen H.
    BMC Cancer; 2019 Jun 14; 19(1):584. PubMed ID: 31200683
    [Abstract] [Full Text] [Related]

  • 2. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
    Chen BY, Ye DF, Xie X, Chen HZ, Lü WG.
    Zhonghua Zhong Liu Za Zhi; 2005 Jan 14; 27(1):33-7. PubMed ID: 15771796
    [Abstract] [Full Text] [Related]

  • 3. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
    Wimberger P, Chebouti I, Kasimir-Bauer S, Lachmann R, Kuhlisch E, Kimmig R, Süleyman E, Kuhlmann JD.
    Gynecol Oncol; 2014 Jun 14; 133(3):467-72. PubMed ID: 24713547
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E, Arias FC, Caso Peláez E, Muñoz Molina GM, Sánchez Hernández I, Muguruza Trueba I, Moreno Balsalobre R, Sacristán López S, Gómez Pinillos A, del Val Toledo Lobo M.
    Cancer; 2009 Apr 15; 115(8):1701-12. PubMed ID: 19197998
    [Abstract] [Full Text] [Related]

  • 5. High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.
    Sopo M, Sallinen H, Hämäläinen K, Kivelä A, Ylä-Herttuala S, Kosma VM, Keski-Nisula L, Anttila M.
    PLoS One; 2020 Apr 15; 15(11):e0241484. PubMed ID: 33151982
    [Abstract] [Full Text] [Related]

  • 6. Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.
    Wang J, Taylor A, Showeil R, Trivedi P, Horimoto Y, Bagwan I, Ewington L, Lam EW, El-Bahrawy MA.
    Cytokine; 2014 Aug 15; 68(2):94-100. PubMed ID: 24845798
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I.
    Clin Exp Metastasis; 2002 Aug 15; 19(2):135-44. PubMed ID: 11964077
    [Abstract] [Full Text] [Related]

  • 8. Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    Goussia A, Simou N, Zagouri F, Manousou K, Lazaridis G, Gogas H, Koutras A, Sotiropoulou M, Pentheroudakis G, Bafaloukos D, Markopoulos C, Patsea H, Christodoulou C, Papakostas P, Zaramboukas T, Samantas E, Kosmidis P, Venizelos V, Karanikiotis C, Papatsibas G, Xepapadakis G, Kalogeras KT, Bamia C, Dimopoulos MA, Malamou-Mitsi V, Fountzilas G, Batistatou A.
    PLoS One; 2018 Aug 15; 13(7):e0200302. PubMed ID: 30063723
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.
    Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Umemoto M, Sakamoto T, Sato S, Mizunuma H, Smith SK.
    Br J Cancer; 2003 Jan 27; 88(2):237-44. PubMed ID: 12610509
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A, Anttonen M, Pociuviene J, Leminen A, Butzow R, Heikinheimo M, Unkila-Kallio L.
    Eur J Endocrinol; 2011 Jan 27; 164(1):115-22. PubMed ID: 21041381
    [Abstract] [Full Text] [Related]

  • 13. The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.
    Skirnisdottir I, Seidal T, Åkerud H.
    Int J Oncol; 2016 Mar 27; 48(3):998-1006. PubMed ID: 26783205
    [Abstract] [Full Text] [Related]

  • 14. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
    Chen H, Ye D, Xie X, Chen B, Lu W.
    Gynecol Oncol; 2004 Sep 27; 94(3):630-5. PubMed ID: 15350351
    [Abstract] [Full Text] [Related]

  • 15. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas LJ, Mongan NP, Persson JL.
    Anticancer Res; 2013 Jun 27; 33(6):2381-90. PubMed ID: 23749886
    [Abstract] [Full Text] [Related]

  • 16. Expression of VEGFR3 in glioma endothelium correlates with tumor grade.
    Grau SJ, Trillsch F, Herms J, Thon N, Nelson PJ, Tonn JC, Goldbrunner R.
    J Neurooncol; 2007 Apr 27; 82(2):141-50. PubMed ID: 17115285
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ, Opeskin K, Coso S, Wu D, Baldwin ME, Williams ED.
    Prostate; 2013 May 27; 73(6):563-72. PubMed ID: 23038639
    [Abstract] [Full Text] [Related]

  • 18. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
    Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Tropé CG, Kristensen GB, Bryne M, Reich R.
    Am J Surg Pathol; 2001 Dec 27; 25(12):1493-500. PubMed ID: 11717538
    [Abstract] [Full Text] [Related]

  • 19. VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer.
    Talagas M, Uguen A, Garlantezec R, Fournier G, Doucet L, Gobin E, Marcorelles P, Volant A, DE Braekeleer M.
    Anticancer Res; 2013 May 27; 33(5):2065-75. PubMed ID: 23645757
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M.
    Cancer; 2004 Sep 15; 101(6):1364-74. PubMed ID: 15368324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.